69452-159 : Deferasirox 125 mg Oral Tablet, for Suspension


NDC: 69452-159
Labeler: Bionpharma Inc.
Product Type: Human Prescription Drug
Drug Name:  Deferasirox
Dosage Form: Oral Tablet, for Suspension
Application #: ANDA210920
Rev. Date: 


Appearance:


Markings: D1
Shapes:  Round
Colors:  White
Size (mm): 10
Segments: * 1

* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 1 indicates a solid pill with no score lines.

NDC Package Codes:

  • 69452-159-13: 30 TABLET, FOR SUSPENSION IN 1 BOTTLE (69452‑159‑13)

Active Ingredients:

  • Deferasirox

Dosage Strength:

  • 125 mg

Inactive Ingredients:

  • Silicon Dioxide
  • Crospovidone
  • Hydroxypropyl Cellulose, Low Substituted
  • Magnesium Stearate
  • Cellulose, Microcrystalline
  • Povidone K30
  • Sodium Lauryl Sulfate /

Pharmaceutical Classes:

  • Cytochrome P450 1A2 Inhibitors [MoA]
  • Cytochrome P450 2C8 Inhibitors [MoA]
  • Cytochrome P450 3A4 Inducers [MoA]
  • Iron Chelating Activity [MoA]
  • Iron Chelator [EPC]

Related Products:

Based on records with the same trade name.
  • 69452-160 Deferasirox 250 mg Oral Tablet, for Suspension by Bionpharma Inc.
  • 69452-161 Deferasirox 500 mg Oral Tablet, for Suspension by Bionpharma Inc.
  • 0093-3515 Deferasirox 360 mg Oral Tablet by Teva Pharmaceuticals USA, Inc.
  • 0093-3516 Deferasirox 180 mg Oral Tablet, Film Coated by Teva Pharmaceuticals USA, Inc.
  • 0093-3517 Deferasirox 90 mg Oral Tablet by Teva Pharmaceuticals USA, Inc.
  • 0591-3853 Deferasirox 180 mg Oral Tablet, Film Coated by Actavis Pharma, Inc.
  • 0591-4730 Deferasirox 90 mg Oral Granule by Actavis Pharma, Inc.
  • 0591-4735 Deferasirox 180 mg Oral Granule by Actavis Pharma, Inc.
  • 0591-4740 Deferasirox 360 mg Oral Granule by Actavis Pharma, Inc.
  • 16714-993 Deferasirox 90 mg Oral Tablet, Film Coated by Northstar Rx LLC.
  • 16714-994 Deferasirox 180 mg Oral Tablet, Film Coated by Northstar Rx LLC.
  • 16714-995 Deferasirox 360 mg Oral Tablet, Film Coated by Northstar Rx LLC.
  • 31722-011 Deferasirox 90 mg Oral Tablet, Film Coated by Camber Pharmaceuticals, Inc.
  • 31722-012 Deferasirox 180 mg Oral Tablet, Film Coated by Camber Pharmaceuticals, Inc.
  • 31722-013 Deferasirox 360 mg Oral Tablet, Film Coated by Camber Pharmaceuticals, Inc.
  • 31722-029 Deferasirox 90 mg Oral Granule by Camber Pharmaceuticals, Inc.
  • 31722-030 Deferasirox 180 mg Oral Granule by Camber Pharmaceuticals, Inc.
  • 31722-031 Deferasirox 360 mg Oral Granule by Camber Pharmaceuticals, Inc.
  • 43598-851 Deferasirox 360 mg Oral Tablet by Dr. Reddy's Laboratories Inc
  • 43598-852 Deferasirox 180 mg Oral Tablet by Dr. Reddy's Laboratories Inc
  • More related products ...

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 69452-159 QR Code

< Prev: 69452-158Next: 69452-160 >




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.